PRODUCTS NOT CURRENTLY AVAILABLE FOR COMMERCIAL SALE

HeLP™ Prostate Cancer Tests

When you’re faced with the possibility of prostate cancer, two questions matter most:

  1. Do I actually have cancer?

  2. If I do, is it the aggressive kind that needs urgent treatment?

HeLP™ tests from Hessian Labs are designed to give you and your doctor clear, reliable answers — using only a simple blood draw.

  • HeLP™ Detect PC

    • Helps show whether cancer is likely to be found on biopsy.

    • Can spare many men an unnecessary biopsy if their cancer risk is low.

    • Looks for specific protein signals linked only to prostate cancer — unlike the PSA test, which can rise for many reasons.

  • HeLP™ Monitor PC

    • Focuses on identifying aggressive prostate cancer.

    • Helps your doctor see if your cancer needs urgent treatment or can be safely watched.

    • Gives you more confidence in making the right decision for your version of the disease.

Why it matters:
Together, the HeLP™ tests reduce uncertainty, minimize unnecessary procedures, and guide the care that’s right for you — so you can move forward with clarity and confidence.

HeLP™ Breast Cancer Tests

When it comes to breast cancer, women and their doctors face three critical questions:

  1. Is the lump or lesion invasive, or not?

  2. If I carry a high-risk gene, is my condition progressing toward cancer?

  3. Is my treatment working for me?

The HeLP™ Breast Cancer tests are designed to give clear answers — from a simple blood draw.

  • HeLP™ Define BC

    • Helps distinguish whether a breast lesion (like DCIS seen on a mammogram) is non-invasive or invasive cancer.

    • Provides clarity so doctors and patients can decide whether urgent treatment is needed.

  • HeLP™ Detect Progression BC (HeLP™ DP BC)

    • For women with genetic risks (BRCA1, BRCA2, Cowden’s, or Lynch syndrome).

    • Detects early signs that the condition may be progressing toward cancer, allowing earlier and more proactive care.

  • HeLP™ Monitor Therapy BC

    • Shows whether targeted therapies are working — or not.

    • Helps patients and doctors adjust treatment sooner, with confidence.

Looking ahead: The HeLP™ platform is also being developed for other diseases, including pancreatic cancer and Alzheimer’s, expanding its potential to help patients across multiple conditions.